Analysts expect Grace Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 563,542.84 | 678,685.41 | 23.66 M | 24.84 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 464,331.40 | 621,975.31 | 19.93 M | 23.00 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 513,937.12 | 650,330.36 | 21.79 M | 23.92 M |
Analysts expect Grace Therapeutics, Inc. to report earnings per share of -0.14 for Q3 26, against a range of -0.15 to -0.13. The most recent reported quarter, Q2 26, came in at -0.11, a 21.4% beat against the -0.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.36 | 0.11 | -0.21 | -0.06 | -0.14 | -0.06 | -0.91 | -0.11 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.34 | -0.27 | -0.22 | -0.25 | -0.25 | -0.21 | -0.12 | -0.13 | -0.13 | -0.12 | -0.10 | -0.09 | -0.10 | -0.04 | 0.21 | 0.49 | ||||||||||
| Low Estimate | -0.38 | -0.31 | -0.24 | -0.27 | -0.29 | -0.23 | -0.14 | -0.15 | -0.15 | -0.12 | -0.10 | -0.11 | -0.10 | -0.04 | 0.17 | 0.41 | ||||||||||
| Consensus Estimate | -0.36 | -0.29 | -0.23 | -0.26 | -0.27 | -0.22 | -0.13 | -0.14 | -0.14 | -0.12 | -0.10 | -0.10 | -0.10 | -0.04 | 0.19 | 0.45 |
Pull Wall Street consensus for Grace Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GRCE&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GRCE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=GRCE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();